Details of Disease
General Information of Disease (ID: DIS1K7GJ)
Disease Name | GNPTG-mucolipidosis | |||||
---|---|---|---|---|---|---|
Synonyms |
mucolipidosis III, Iranian variant form; mucolipidosis III gamma; mucolipidosis 3 gamma; ML 3C; mucolipidosis 3C; mucolipidosis III, variant form; mucolipidosis III, complementation group C; mucolipidosis type 3 gamma; ML 3 gamma; ML III gamma; GNPTG-mucolipidosis; mucolipidosis type III gamma
|
|||||
Definition |
A very rare lysosomal disease, that has most often been observed in the Middle East, characterized by a progressive slowing of the growth rate in early childhood; stiffness and pain in shoulders, hips, and finger joints; a gradual, mild coarsening of facial features; and by a slower progression, milder clinical course and longer life expectancy than that seen in mucolipidosis II and mucolipidosis III alpha/beta. Cognitive function is normal or only slightly impaired and retinitis pigmentosa has been reported in a few patients. Many survive into early adulthood, but ultimately succumb to cardiorespiratory insufficiency.
|
|||||
Disease Hierarchy | ||||||
Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
This Disease Is Related to 1 DOT Molecule(s)
|
|||||||||||||||||||||||||
References